A list of profitable growth stocks includes Genmab (NASDAQ:GMAB), a biotech company focused on antibody therapeutics. With recent approvals for innovative cancer treatments, Genmab ranks 9th on the list. AI stocks are also promising for higher returns.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing